Monday, August 10, 2026

Constellation Beats Earnings for Fourth Year, EXL Guides 10-12% EPS Growth for 2026

Constellation delivered full-year earnings exceeding guidance for the fourth consecutive year, driven by nuclear fleet performance and commercial execution. EXL projects 2026 adjusted diluted EPS of $2.14 to $2.19, marking a 10-12% increase over 2025. Gartner expects Contract Value acceleration in 2026 despite market volatility.

Constellation Beats Earnings for Fourth Year, EXL Guides 10-12% EPS Growth for 2026
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Constellation reported full-year earnings that exceeded the midpoint of its guidance range for the fourth straight year, according to CEO Shane Smith. The performance reflects commercial execution and industry-leading results from the company's nuclear fleet.

EXL forecasts 2026 adjusted diluted EPS between $2.14 and $2.19, representing a 10% to 12% increase over 2025 levels, CFO Maurizio Nicolelli stated. The guidance signals confidence in the company's growth trajectory amid broader corporate restructuring trends.

Gartner outlined a $6.455 billion revenue target for 2026 as its transformation initiatives gain momentum. CFO Craig Safian said Contract Value will accelerate throughout 2026, though he acknowledged the environment "still remains pretty chaotic." The company expects both CV and CV growth rates to improve over the course of the year.

The earnings beats and bullish guidance come as corporate restructuring activity intensifies across sectors. Multiple companies are executing strategic separations, with leadership transitions accompanying these transformations through CFO changes.

Cross-border M&A activity is also picking up, including transactions involving Keurig Dr Pepper, JDE Peet's, and NIBC. Companies are pairing these moves with aggressive margin expansion targets designed to unlock shareholder value.

Ocham's Razor Capital Limited announced plans to change its business to match Pelican's current operations, adding to the wave of corporate transformations. The resulting entity will operate under a revised business model aligned with strategic objectives.

The coordinated restructuring activities signal a shift in corporate finance strategy, with companies prioritizing operational efficiency and focused business units. Strong earnings performance and double-digit growth projections are fueling investor confidence in these transformation plays.

Stock buyback authorizations are accompanying the restructuring moves, providing additional support for share prices. The combination of earnings beats, margin expansion plans, and capital return programs is driving bullish sentiment heading into 2026.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
  1. [1]News articleYahoo Finance· February 24, 2026
    Constellation Reports Fourth Quarter and Full Year 2025 Results
  2. [2]News articleYahoo Finance· February 24, 2026
    EXL Reports 2025 Fourth Quarter and Year-End Results; Issues 2026 Guidance
  3. [3]News articleSeeking Alpha· February 3, 2026
    Gartner outlines $6.455B revenue target for 2026 as transformation accelerates contract value growth
  4. [4]News articleYahoo Finance· February 23, 2026
    Keurig Dr Pepper Announces Updated Financing Plan for JDE Peet's Acquisition
  5. [5]News articleYahoo Finance· February 23, 2026
    Ocham's Razor Capital Limited Announces Reverse Takeover Transaction With Pelican Canada Inc. and Brokered Financing
  6. [6]News articleYahoo Finance· March 3, 2026
    Sturm Ruger (RGR) Q4 2025 Earnings Call Transcript
  7. [7]Press releaseGlobeNewswire· February 11, 2026
    ABN AMRO posts net profit of EUR 410 million in Q4 2025
  8. [8]Press releaseGlobeNewswire· December 10, 2025
    Aegon Capital Markets Day 2025 – The Next Frontier
  9. [9]News articleYahoo Finance· February 10, 2026
    Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities
  10. [10]Press releaseGlobeNewswire· February 3, 2026
    eQ Oyj Kutsu varsinaiseen yhtiökokoukseen 2026
  11. [11]News articleYahoo Finance· February 7, 2026
    Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)
  12. [12]News articleYahoo Finance· February 28, 2026
    Pursuit Attractions and Hospitality Q4 Earnings Call Highlights